{
  "retracted": false,
  "timestamp": 1592870400000,
  "updates": [
    {
      "timestamp": 1592898070876,
      "identifier": {
        "doi": "10.1186/s13075-020-02247-3"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1186/s13075-020-2125-2"
  },
  "journal": "Arthritis Research & Therapy",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan"
}
